Here, we present a conceptual overview on CPT II deficiency based on our own findings and on results from other studies addressing clinical, biochemical, histological, immunohistological and genetic aspects, as well as recent advancements in diagnosis and therapeutic strategies in this disorder. This evidence concerns the gene CPT2 and hyperinsulinemic hypoglycemia, familial, 4.